Role of Cardiac Myocyte CXCR4 Expression in Development and Left Ventricular Remodeling After Acute Myocardial Infarction

被引:60
作者
Agarwal, Udit [1 ,2 ,3 ]
Ghalayini, Wael [1 ,2 ,3 ]
Dong, Feng [1 ,2 ,3 ]
Weber, Kristal [1 ,2 ,3 ]
Zou, Yong-Rui [7 ]
Rabbany, Sina Y. [5 ,8 ]
Rafii, Shahin [5 ,6 ]
Penn, Marc S. [1 ,2 ,3 ,4 ]
机构
[1] Cleveland Clin, Dept Cardiovasc Med, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Stem Cell Biol, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44195 USA
[3] Cleveland Clin, Dept Regenerat Med, Skirball Lab Cardiovasc Cellular Therapeut, Cleveland, OH 44195 USA
[4] Cleveland Clin, Inst Heart & Vasc, Ctr Cardiovasc Cell Therapy, Cleveland, OH 44195 USA
[5] Cornell Univ, Weill Med Coll, Dept Med Genet, New York, NY 10021 USA
[6] Cornell Univ, Weill Med Coll, Howard Hughes Med Inst, New York, NY 10021 USA
[7] Long Isl Jewish Med Ctr, Feinstein Lab Hematopoiesis, New York, NY USA
[8] Hofstra Univ, Bioengn Program, Hempstead, NY 11550 USA
关键词
stem cells; myocardial infarction; cardiogenesis; CHEMOKINE RECEPTOR CXCR4; CELL RECRUITMENT; PROGENITOR CELLS; MICE DEFICIENT; SDF-1; MYELOPEROXIDASE; TRANSPLANTATION; CARDIOMYOPATHY; HEMATOPOIESIS; REGENERATION;
D O I
10.1161/CIRCRESAHA.110.223289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Stromal cell-derived factor (SDF)-1/CXCR4 axis has an instrumental role during cardiac development and has been shown to be a potential therapeutic target for optimizing ventricular remodeling after acute myocardial infarction (AMI) and in ischemic cardiomyopathy. Although a therapeutic target, the specific role of cardiac myocyte CXCR4 (CM-CXCR4) expression following cardiogenesis and survival of cardiac myocyte and left ventricular remodeling after AMI is unknown. Objective: We hypothesized that cardiac myocyte derived CXCR4 is critical for cardiac development, but it may have no role in adulthood secondary to the short transient expression of SDF-1 and the delayed expression of CM-CXCR4 following AMI. To address this issue, we developed congenital and conditional CM-CXCR4(-/-) mouse models. Methods and Results: Two strains of CM-CXCR4(flox/flox) mice were generated by crossing CXCR4(flox/flox) mice with MCM-Cre(+/-) mouse and MLC2v-Cre(+/-) mouse on the C57BL/6J background, yielding CXCR4(flox/flox) MCM-Cre(+/-) and CXCR4(flox/flox)MLC2v-Cre(+/-) mice. Studies demonstrated recombination in both models congenitally in the MLC2v-Cre(+/-) mice and following tamoxifen administration in the MCM-Cre(+/-) mice. Surprisingly the CXCR4(flox/flox)MLC2v-Cre(+/-) are viable, had normal cardiac function, and had no evidence of ventricular septal defect. CXCR4(flox/flox)MCM(+/-) treated with tamoxifen 2 weeks before AMI demonstrated 90% decrease in cardiac CXCR4 expression 48 hours after AMI. Twenty-one days post AMI, echocardiography revealed no statistically significant difference in the wall thickness, left ventricular dimensions or ejection fraction (40.9 +/- 7.5 versus 34.4 +/- 2.6%) in CXCR4(flox/flox) mice versus CM-CXCR4(-/-) mice regardless of strategy of Cre expression. No differences in vascular density (2369 +/- 131 versus 2471 +/- 126 vessels/mm(2); CXCR4(flox/flox) versus CM-CXCR4(-/-) mouse), infarct size, collagen content, or noninfarct zone cardiac myocyte size were observed 21 days after AMI. Conclusions: We conclude that cardiac myocyte-derived CXCR4 is not essential for cardiac development and, potentially because of the mismatch in timings of peaks of SDF-1 and CXCR4, has no major role in ventricular remodeling after AMI. (Circ Res. 2010;107:667-676.)
引用
收藏
页码:667 / U236
页数:13
相关论文
共 40 条
  • [1] Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction
    Askari, AT
    Brennan, ML
    Zhou, XR
    Drinko, J
    Morehead, A
    Thomas, JD
    Topol, EJ
    Hazen, SL
    Penn, MS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) : 615 - 624
  • [2] Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
    Askari, AT
    Unzek, S
    Popovic, ZB
    Goldman, CK
    Forudi, F
    Kiedrowski, M
    Rovner, A
    Ellis, SG
    Thomas, JD
    DiCorleto, PE
    Topol, EJ
    Penn, MS
    [J]. LANCET, 2003, 362 (9385) : 697 - 703
  • [3] Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI)
    Assmus, B
    Schächinger, V
    Teupe, C
    Britten, M
    Lehmann, R
    Döbert, N
    Grünwald, F
    Aicher, A
    Urbich, C
    Martin, H
    Hoelzer, D
    Dimmeler, S
    Zeiher, AM
    [J]. CIRCULATION, 2002, 106 (24) : 3009 - 3017
  • [4] Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI) -: Mechanistic insights from serial contrast-enhanced magnetic resonance imaging
    Britten, MB
    Abolmaali, ND
    Assmus, B
    Lehmann, R
    Honold, J
    Schmitt, J
    Vogl, TJ
    Martin, H
    Schächinger, V
    Dimmeler, S
    Zeiher, AM
    [J]. CIRCULATION, 2003, 108 (18) : 2212 - 2218
  • [5] Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis
    Brunner, Stefan
    Winogradow, Janina
    Huber, Bruno C.
    Zaruba, Marc-Michael
    Fischer, Rebekka
    David, Robert
    Assmann, Gerald
    Herbach, Nadja
    Wanke, Ruediger
    Mueller-Hoecker, Josef
    Franz, Wolfgang-Michael
    [J]. FASEB JOURNAL, 2009, 23 (02) : 351 - 361
  • [6] Effects of CXCR4 Gene Transfer on Cardiac Function After Ischemia-Reperfusion Injury
    Chen, Jiqiu
    Chemaly, Elie
    Liang, Lifan
    Kho, Changwon
    Lee, Ahyoung
    Park, Jaeho
    Altman, Perry
    Schecter, Alison D.
    Hajjar, Roger J.
    Tarzami, Sima T.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (04) : 1705 - 1715
  • [7] Czarnowska E, 2007, J PHYSIOL PHARMACOL, V58, P729
  • [8] Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
    Damås, JK
    Eiken, HG
    Oie, E
    Bjerkeli, V
    Yndestad, A
    Ueland, T
    Tonnessen, T
    Geiran, OR
    Aass, H
    Simonsen, S
    Christensen, G
    Froland, SS
    Attramadal, H
    Gullestad, L
    Aukrust, P
    [J]. CARDIOVASCULAR RESEARCH, 2000, 47 (04) : 778 - 787
  • [9] Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
    Darash-Yahana, M
    Pikarsky, E
    Abramovitch, R
    Zeira, E
    Pal, B
    Karplus, R
    Beider, K
    Avniel, S
    Kasem, S
    Galun, E
    Peled, A
    [J]. FASEB JOURNAL, 2004, 18 (09) : 1240 - +
  • [10] SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells
    De Falco, E
    Porcelli, D
    Torella, AR
    Straino, S
    Iachininoto, MG
    Orlandi, A
    Truffa, S
    Biglioli, P
    Napolitano, M
    Capogrossi, MC
    Pesce, M
    [J]. BLOOD, 2004, 104 (12) : 3472 - 3482